First Tracks Biotherapeutics, Inc.
TRAX
$44.04
$0.010.02%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | 33.89% | 10.07% | |||
| Total Depreciation and Amortization | 65.60% | -0.83% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -26.36% | -0.33% | |||
| Change in Net Operating Assets | -214.49% | 36.55% | |||
| Cash from Operations | 1.97% | 14.15% | |||
| Capital Expenditure | -47.06% | -11.43% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -100.00% | 144.87% | |||
| Cash from Investing | -100.07% | 145.19% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 3,450.04% | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -717.86% | -1,011.56% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -883.13% | -122.31% | |||